Some thoughts on resistance to cancer chemotherapy

Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer.

Urology·2001

Clinical strategy for the development of angiogenesis inhibitors.

The oncologist·2000

Clinical research and drug development of antivirals in HIV: an industry perspective.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1995

Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group.

NCI monographs : a publication of the National Cancer Institute·1988

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1987

Calibrated phase II clinical trials in oncology.

Statistics in medicine·1986

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Cancer treatment reviews·2026

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Cancer treatment reviews·2026

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Cancer treatment reviews·2026

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Cancer treatment reviews·2026

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.

Cancer treatment reviews·2026

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Cancer treatment reviews·2026

The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review.

Cancer management and research·2026

Environmental endocrine disruptors activate CBX2 to disrupt cholesterol homeostasis in PCOS.

The Journal of steroid biochemistry and molecular biology·2026

Phytochemical characterization of methanolic extract of Cuminum cyminum seeds and its anticancer efficacy against human oral cancer.

Tissue & cell·2026

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Pharmacological research·2026

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

Translational oncology·2026

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Materials today. Bio·2026

Related Experiment Videos

Some thoughts on resistance to cancer chemotherapy

Related Concept Videos

Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer.

Clinical strategy for the development of angiogenesis inhibitors.

Clinical research and drug development of antivirals in HIV: an industry perspective.

Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group.

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.

Calibrated phase II clinical trials in oncology.

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review.

Environmental endocrine disruptors activate CBX2 to disrupt cholesterol homeostasis in PCOS.

Phytochemical characterization of methanolic extract of Cuminum cyminum seeds and its anticancer efficacy against human oral cancer.

Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes.

Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathway.

A synergistic cascade nanoreactor breaks bladder cancer chemoresistance: Synergizing cholesterol metabolism reprogramming with cGAS-STING-mediated metallotherapy.

Related Experiment Videos

Some thoughts on resistance to cancer chemotherapy

Related Concept Videos

Related Articles